Matthew Call - 05 Dec 2023 Form 4 Insider Report for iTeos Therapeutics, Inc. (ITOS)

Role
Chief Operating Officer
Signature
/s/ Adi Osovsky, as Attorney-in-Fact
Issuer symbol
ITOS
Transactions as of
05 Dec 2023
Net transactions value
$0
Form type
4
Filing time
07 Dec 2023, 20:22:07 UTC
Previous filing
29 Mar 2023
Next filing
08 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITOS Common Stock Award $0 +44,000 +47% $0.000000 137,898 05 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. All of the shares of common stock underlying such RSUs will vest on December 5, 2025, subject to the Reporting Person's continued service to the Issuer.